EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Soluble CD14 and Osteoprotegerin Associate with Ankle-Brachial Index as a Measure of Arterial Stiffness in Patients with Mild-to-Moderate Chronic Kidney Disease in a Five-Year Prospective Study

Senka Sendic, Ladan Mansouri, Mun-Gwan Hong, Jochen M Schwenk, Maria J Eriksson, Britta Hylander, Joachim Lundahl, Stefan H Jacobson

Cardiorenal Medicine · 2023

DOI: 10.1159/000530985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiorenal Medicine, 2023. Verfasst von Senka Sendic und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Biomarkers, Lipopolysaccharide Receptors, Osteoprotegerin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Vascular lesions and arterial stiffness appear at early stages of chronic kidney disease (CKD) and follow an accelerated course with disease progression, contributing to high cardiovascular mortality. There are limited prospective data on mechanisms contributing to progression of arterial stiffness in mild-to-moderate CKD (stages 2–3).

Methods

We applied an affinity proteomics approach to identify candidates of circulating biomarkers with potential impact on vascular lesions in CKD and selected soluble cluster of differentiation 14 (sCD14), angiogenin (ANG), and osteoprotegerin (OPG) for further analysis. We studied their association with ankle-brachial index (ABI) and carotid intima-media thickness, as measures of arteriosclerosis and atherosclerosis, respectively, in 48 patients with CKD stages 2–3, who were prospectively followed and intensively treated for 5 years, and 44 healthy controls.

Results

Concentrations of sCD14 (p < 0.001), ANG (p < 0.001), and OPG (p < 0.05) were higher in patients with CKD 2–3 at baseline, and sCD14 (p < 0.001) and ANG (p < 0.001) remained elevated in CKD patients at follow-up. There were positive correlations between ABI and sCD14 levels (r = 0.36, p = 0.01) and between ABI and OPG (r = 0.31, p = 0.03) at 5 years. The changes in sCD14 during follow-up correlated to changes in ABI from baseline to 5 years (r = 0.41, p = 0.004).

Conclusion

Elevated levels of circulating sCD14 and OPG in patients with CKD 2–3 were significantly associated with ABI, a measure of arterial stiffness. An increase in sCD14 over time in CKD 2–3 patients was associated with a corresponding increase in ABI. Further studies are needed to examine if early intensive multifactorial medication to align with international treatment targets may influence cardiovascular outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicBiomarkersLipopolysaccharide ReceptorsOsteoprotegerinHumansAnkle Brachial IndexAdolescentAdultMiddle AgedAgedProspective StudiesMaleFemaleFollow-Up StudiesPatient Acuity

Stichwörter der Autor:innen

Ankle-brachial indexArterial stiffnessChronic kidney diseaseSoluble cluster of differentiation 14

Substanzen

BiomarkersCD14 protein, humanLipopolysaccharide ReceptorsTNFRSF11B protein, humanOsteoprotegerin

Autor:innen und Institutionen

  • Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital, Stockholm, Sweden.
  • Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
  • Affinity Proteomics, Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Department of Clinical Physiology, Karolinska University Hospital, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Division of Nephrology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Zitieren

APA

Sendic, S., Mansouri, L., Hong, M. G., Schwenk, J. M., Eriksson, M. J., Hylander, B., Lundahl, J., & Jacobson, S. H. (2023). Soluble CD14 and Osteoprotegerin Associate with Ankle-Brachial Index as a Measure of Arterial Stiffness in Patients with Mild-to-Moderate Chronic Kidney Disease in a Five-Year Prospective Study. Cardiorenal Medicine. https://doi.org/10.1159/000530985

Vancouver

Sendic S, Mansouri L, Hong MG, Schwenk JM, Eriksson MJ, Hylander B, et al. Soluble CD14 and Osteoprotegerin Associate with Ankle-Brachial Index as a Measure of Arterial Stiffness in Patients with Mild-to-Moderate Chronic Kidney Disease in a Five-Year Prospective Study. Cardiorenal Medicine. 2023. doi:10.1159/000530985

BibTeX
@article{Sendic2023,
  author = {Sendic, Senka and Mansouri, Ladan and Hong, Mun-Gwan and Schwenk, Jochen M and Eriksson, Maria J and Hylander, Britta and Lundahl, Joachim and Jacobson, Stefan H},
  title = {Soluble CD14 and Osteoprotegerin Associate with Ankle-Brachial Index as a Measure of Arterial Stiffness in Patients with Mild-to-Moderate Chronic Kidney Disease in a Five-Year Prospective Study},
  journal = {Cardiorenal Medicine},
  year = {2023},
  doi = {10.1159/000530985}
}
Kostenlos starten →